Newsroom
News from Firalis Group
Announcements, scientific results and corporate news from the group and its companies.
-
Firalis Molecular Precision becomes Precursion
Firalis has sold its majority stake in Firalis Molecular Precision to Janvier Group Biosciences, and the business now operates as Precursion.
-
Firalis and Amoneta at AD/PD™ 2026 in Copenhagen
A fourth consecutive year at the International Conference on Alzheimer’s and Parkinson’s Diseases. The APOE work is what the team brings to it.
-
Amoneta’s APO-Easy® genotyping kit is CE-marked under the EU IVDR
The group’s APOE genotyping test clears Regulation (EU) 2017/746 — the framework that replaced the IVD Directive and raised the bar for every European test.
-
Huningue hosts the CombiDiag doctoral network for a summer school
For four days in June, the European doctoral network on combined diagnostics worked from the group’s laboratories, sampling centre and biobank in Alsace.
